These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32986757)

  • 41. Genetic modifiers of upper limb function in Duchenne muscular dystrophy.
    Sabbatini D; Fusto A; Vianello S; Villa M; Janik J; D'Angelo G; Diella E; Magri F; Comi GP; Panicucci C; Bruno C; D'Amico A; Bertini E; Astrea G; Battini R; Politano L; Masson R; Baranello G; Previtali SC; Messina S; Vita G; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Hoffman EP; Morgenroth L; Gordish-Dressman H; Duong T; McDonald CM; Bello L; Pegoraro E
    J Neurol; 2022 Sep; 269(9):4884-4894. PubMed ID: 35513612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring daily physical activity of upper extremity in young and adolescent boys with Duchenne muscular dystrophy: A pilot study.
    van der Geest A; Essers JMN; Bergsma A; Jansen M; de Groot IJM
    Muscle Nerve; 2020 Mar; 61(3):293-300. PubMed ID: 31742708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reliability and validity analyses of the North Star Ambulatory Assessment in Brazilian Portuguese.
    Okama LO; Zampieri LM; Ramos CL; Toledo FO; Alves CRJ; Mattiello-Sverzut AC; Mayhew A; Sobreira CFR
    Neuromuscul Disord; 2017 Aug; 27(8):723-729. PubMed ID: 28648683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1.
    McDonald CM; Mayer OH; Hor KN; Miller D; Goemans N; Henricson EK; Marden JR; Freimark J; Lane H; Zhang A; Frean M; Trifillis P; Koladicz K; Signorovitch J;
    J Neuromuscul Dis; 2023; 10(1):67-79. PubMed ID: 36565131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and effectiveness of a novel dynamic arm support in persons with spinal muscular atrophy and duchenne muscular dystrophy.
    Janssen MMHP; Horstik J; Klap P; de Groot IJM
    J Neuroeng Rehabil; 2021 May; 18(1):84. PubMed ID: 34020668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy.
    Connolly AM; Malkus EC; Mendell JR; Flanigan KM; Miller JP; Schierbecker JR; Siener CA; Golumbek PT; Zaidman CM; Mcdonald CM; Johnson L; Nicorici A; Karachunski PI; Day JW; Kelecic JM; Lowes LP; Alfano LN; Darras BT; Kang PB; Quigley J; Pasternak AE; Florence JM;
    Muscle Nerve; 2015 Apr; 51(4):522-32. PubMed ID: 25056178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different profiles of upper limb function in four types of neuromuscular disorders.
    Bergsma A; Janssen MMHP; Geurts ACH; Cup EHC; de Groot IJM
    Neuromuscul Disord; 2017 Dec; 27(12):1115-1122. PubMed ID: 29033278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys.
    Pane M; Mazzone ES; Sivo S; Fanelli L; De Sanctis R; D'Amico A; Messina S; Battini R; Bianco F; Scutifero M; Petillo R; Frosini S; Scalise R; Vita GL; Bruno C; Pedemonte M; Mongini T; Pegoraro E; Brustia F; Gardani A; Berardinelli A; Lanzillotta V; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Busato F; Bonfiglio S; Rolle E; Colia G; Bonetti A; Palermo C; Graziano A; D'Angelo G; Pini A; Corlatti A; Gorni K; Baranello G; Antonaci L; Bertini E; Politano L; Mercuri E
    PLoS Curr; 2014 Oct; 6():. PubMed ID: 25642376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reliability of home-based, motor function measure in hereditary neuromuscular diseases.
    Ruiz-Cortes X; Ortiz-Corredor F; Mendoza-Pulido C
    J Int Med Res; 2017 Feb; 45(1):261-271. PubMed ID: 28222643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virtual Reality Computer Gaming with Dynamic Arm Support in Boys with Duchenne Muscular Dystrophy.
    Heutinck L; Jansen M; van den Elzen Y; van der Pijl D; de Groot IJM
    J Neuromuscul Dis; 2018; 5(3):359-372. PubMed ID: 29991140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of instruments assessing activity and participation of people with muscular dystrophy: A systematic review of participant-reported outcome measures.
    Andrade KKS; Soares LA; Macedo CC; Bispo NR; Sousa Junior RR; Oliveira VC; Leite HR; Gaiad TP
    Dev Med Child Neurol; 2022 Dec; 64(12):1453-1461. PubMed ID: 35862363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Motor Compensation Strategies for Reduced Upper Limb Function Among Individuals With Duchenne Muscular Dystrophy.
    Maciel FKL; Santos ALYDS; Artilheiro MC; Sá CDSC
    Percept Mot Skills; 2021 Jun; 128(3):1059-1077. PubMed ID: 33726582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy.
    Scott E; Eagle M; Mayhew A; Freeman J; Main M; Sheehan J; Manzur A; Muntoni F;
    Physiother Res Int; 2012 Jun; 17(2):101-9. PubMed ID: 21954141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales.
    Davis SE; Hynan LS; Limbers CA; Andersen CM; Greene MC; Varni JW; Iannaccone ST
    J Clin Neuromuscul Dis; 2010 Mar; 11(3):97-109. PubMed ID: 20215981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy.
    Hogrel JY; Wary C; Moraux A; Azzabou N; Decostre V; Ollivier G; Canal A; Lilien C; Ledoux I; Annoussamy M; Reguiba N; Gidaro T; Le Moing AG; Cardas R; Voit T; Carlier PG; Servais L
    Neurology; 2016 Mar; 86(11):1022-30. PubMed ID: 26888987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM.
    Klingels K; Mayhew AG; Mazzone ES; Duong T; Decostre V; Werlauff U; Vroom E; Mercuri E; Goemans NM;
    Dev Med Child Neurol; 2017 Feb; 59(2):224-231. PubMed ID: 27671699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial.
    Taylor M; Jefferies J; Byrne B; Lima J; Ambale-Venkatesh B; Ostovaneh MR; Makkar R; Goldstein B; Smith RR; Fudge J; Malliaras K; Fedor B; Rudy J; Pogoda JM; Marbán L; Ascheim DD; Marbán E; Victor RG
    Neurology; 2019 Feb; 92(8):e866-e878. PubMed ID: 30674601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variables associated with upper extremity function in patients with Duchenne muscular dystrophy.
    Janssen MM; Hendriks JC; Geurts AC; de Groot IJ
    J Neurol; 2016 Sep; 263(9):1810-8. PubMed ID: 27314968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association between trunk control and upper limb functions of children with Duchenne muscular dystrophy.
    Bulut N; Alemdaroğlu-Gürbüz I; Topaloğlu H; Yılmaz Ö; Karaduman A
    Physiother Theory Pract; 2022 Jan; 38(1):46-54. PubMed ID: 32013643
    [No Abstract]   [Full Text] [Related]  

  • 60. Cumulative jerk as an outcome measure in nonambulatory Duchenne muscular dystrophy.
    Fujii T; Takeshita E; Iwata Y; Yajima H; Nozaki F; Mori M; Kumada T
    Brain Dev; 2019 Oct; 41(9):796-802. PubMed ID: 31213334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.